FDA grants IND clearance for GT Biopharma’s Phase I leukaemia treatment trial
The trial aims to evaluate several critical aspects, including the safety profile, pharmacokinetics, pharmacodynamics.
28 June 2024
28 June 2024
The trial aims to evaluate several critical aspects, including the safety profile, pharmacokinetics, pharmacodynamics.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.